Fresenius Medical Care AG (WBO:FME)
€ 44.37 1.26 (2.92%) Market Cap: 13.02 Bil Enterprise Value: 23.68 Bil PE Ratio: 19.75 PB Ratio: 0.96 GF Score: 73/100

Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 12:30AM GMT
Release Date Price: €67.4 (+1.69%)
David James Adlington
JP Morgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research

Great. Good afternoon, everybody. I'm David Adlington, head of the research group for the European medtech and services in London. It's my pleasure to introduce Rice Powell, CEO of Fresenius Medical Care. There is no breakout session afterwards. Thanks.

Robert Maurice Powell
Fresenius Medical Care AG & Co. KGaA - Chairman of the Management Board & CEO of Fresenius Medical Care Mgmt AG

Thank you, David. Before I get into my prepared remarks, I'd like to introduce to you, she's down here in front, Helen Giza, our new CFO. She's been here 60 days, and she's still standing. That's a good thing. Helen, please.

So you'll notice up on the top left, we're talking about 2018. I'm not living in a time warp, but 2018 is the last full year set of numbers we have at the moment. We haven't done Q4, so we're going to give you some view of '18 as a baseline, and then I'll go through the third quarter earnings and give you some detail

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot